Lykos Therapeutics
PrivateLast Round
Series B
May 30, 2025
Total Funding Raised
$150M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lykos Therapeutics is a pharmaceutical company focused on the research and development of psychedelic medicines and therapies to treat mental health conditions, with an initial focus on post-traumatic stress disorder (PTSD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lykos Therapeutics Comparables
Compare Lykos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 87% | |
| Apex Labs Ltd. | 80% | |
| Frontier Pharma LLC | 78% |
Lykos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 30, 2025 | ||||
| Series A | Jan 5, 2024 |
Lykos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vine Ventures | Series A |
| Steven & Alexandra Cohen Foundation | Series A |
| Bail Capital | Series A |
| Wisdom Ventures | Series A |
| KittyHawk Ventures | Series A |
| Helena Special Investments | Series A |
| Tabula Rasa Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 36% MoM.
Lykos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lykos Therapeutics's valuation, stock price, and market status.
Is Lykos Therapeutics a public or private company?
Lykos Therapeutics is a private company.
What is the current stock price of Lykos Therapeutics?
Lykos Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lykos Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lykos Therapeutics worth (valuation)?
Valuation information for Lykos Therapeutics is not publicly available.
Can I buy Lykos Therapeutics stock?
Lykos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lykos Therapeutics's last funding round?
Lykos Therapeutics's most recent funding round was Series B on May 30, 2025.
Who are the main investors in Lykos Therapeutics?
Key investors in Lykos Therapeutics include Helena Special Investments.
Will Lykos Therapeutics IPO soon?
No public IPO plans have been announced for Lykos Therapeutics.
How can I track Lykos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lykos Therapeutics's shares on secondary markets.